Circular DNA trapped in micronuclei weakened cancer cells
When circular cancer DNA segregated into micronuclei during cell division, laboratory models showed a decline in gene activity and cell growth. Among 86 neuroblastoma samples with MYCN amplification, tumors carrying a higher share of these structures were associated with better survival. The Nature Genetics study did not test a treatment; its patient finding is observational and needs independent validation.
Science··Evening
DNA circles left the main nucleus during division
Circular DNA outside chromosomes can carry multiple copies of genes that help cancer cells grow. In cell models, the investigators found that replication stress and targeted DNA damage weakened the circles’ attachment to chromosomes. During division, some freed circles were partitioned into membrane-bounded micronuclei separate from the principal nucleus. Live imaging showed uneven inheritance: clusters of circles could accumulate in one daughter cell instead of dividing evenly between the two.[1]
DNA copy number and gene activity diverged
The team isolated individual micronuclei and sequenced their DNA, finding that circles carrying different cancer genes could share one compartment. Compared with circles in the main nucleus, sequestered DNA had weaker signs of active transcription and less RNA polymerase activity. Copy number therefore did not describe how much amplified DNA remained functionally available. Daughter cells inheriting substantial circular DNA in micronuclei divided later or died more often in the experimental models.[1]
Patient association does not prove a treatment
A separate observational analysis examined samples from 86 neuroblastoma patients with MYCN amplification, collected before treatment. Tumors with a larger proportion of DNA-bearing micronuclei were linked to better overall and event-free survival. Patients had not been randomly assigned to any intervention that moved DNA into micronuclei. Total circular DNA abundance and the overall micronucleus count did not independently show the same association. Other patient cohorts and intervention-safety studies are needed before this can inform care.[1]
